31 research outputs found
In situ scanning electron microscopy indentation studies on multilayer nitride films: Methodology and deformation mechanisms
Systematic studies of the deformation mechanisms of multilayer transition metal nitride coatings TiN/CrN, TiN/NbN, and NbN/CrN, and corresponding reference coatings of TiN, NbN, and CrN deposited by a direct current (dc) magnetron sputtering process onto silicon 〈100〉 have been performed. Mechanical characterization was conducted using a combination of microindentation and nanoindentation in the load range 30 to 150 mN and 0.5 to 3.5 mN, respectively. For both load ranges, scanning electron microscopy (SEM) in situ indentation was used to observe the indentation process including any pileup, sink-in, and fracture mechanisms specific to each coating. The coatings' microstructure, both before and after indentation, was analyzed using transmission electron microscopy (TEM). It was possible to both correlate the indentation load-displacement response to surface roughness effects and fracture modes (substrate and film cracking) and observe deformation mechanisms within the coating
Scale effects for strength, ductility, and toughness in "brittle” materials
Decreasing scales effectively increase nearly all important mechanical properties of at least some "brittle” materials below 100 nm. With an emphasis on silicon nanopillars, nanowires, and nanospheres, it is shown that strength, ductility, and toughness all increase roughly with the inverse radius of the appropriate dimension. This is shown experimentally as well as on a mechanistic basis using a proposed dislocation shielding model. Theoretically, this collects a reasonable array of semiconductors and ceramics onto the same field using fundamental physical parameters. This gives proportionality between fracture toughness and the other mechanical properties. Additionally, this leads to a fundamental concept of work per unit fracture area, which predicts the critical event for brittle fracture. In semibrittle materials such as silicon, this can occur at room temperature when the scale is sufficiently small. When the local stress associated with dislocation nucleation increases to that sufficient to break bonds, an instability occurs resulting in fractur
SU(2)U(1) Gauge Symmetry in High Superconductivity
The square lattice structure of layers and the strongly correlated
property of electrons indicate that the high superconductivity in
cuprates can be described by a SO(5) coherent pairing state in which a
SU(2)U(1) gauge symmetry is embedded. The spin and charge
fluctuations that characterize the low energy magnetic excitations in cuprates
are controlled by this intrinsic SU(2)U(1) gauge symmetry.Comment: 4 pages Revtex fil
The association between hospital variation in curative treatment for esophagogastric cancer and health-related quality of life and survival
Background: As previous studies showed significant hospital variation in curative treatment of esophagogastric cancer, this study assesses the association between this variation and overall, cancer-specific and recurrence-free survival, and Health-Related Quality of Life (HRQoL). Methods: Patients diagnosed with potentially curable esophageal or gastric cancer between 2015 and 2018 as registered in the Netherlands Cancer Registry were included. Data on overall survival was available for all patients, data on cancer-specific and recurrence-free survival and HRQoL was available for subgroups. Patients were classified according to diagnosis in hospitals with low, medium or high probability of treatment with curative intent (LP, MP or HP). Multivariable models were used to assess the association between LP, MP and HP hospitals and HRQoL and survival. Results: This study includes 7,199 patients with esophageal, and 2,407 with gastric cancer. Overall and cancer-specific survival was better for patients diagnosed in HP versus LP hospitals for both esophageal (HR = 0.82, 95%CI:0.77–0.88 and HR = 0.82, 95%CI:0.75–0.91, respectively), and gastric cancer (HR = 0.82, 95%CI:0.73–0.92 and HR = 0.74, 95%CI:0.64–0.87, respectively). These differences disappeared after adjustments for treatment. Recurrence-free survival was worse for gastric cancer patients diagnosed in HP hospitals (HR = 1.50, 95%CI:1.14–1.96), which disappeared after adjustment for radicality of surgery. Minor, but no clinically relevant, differences in HRQoL were observed.Conclusions: Patients diagnosed in hospitals with a high probability of treatment with curative intent have a better overall and cancer-specific but not recurrence-free survival, while minor differences in HRQoL were observed.</p
The association between hospital variation in curative treatment for esophagogastric cancer and health-related quality of life and survival
Background: As previous studies showed significant hospital variation in curative treatment of esophagogastric cancer, this study assesses the association between this variation and overall, cancer-specific and recurrence-free survival, and Health-Related Quality of Life (HRQoL). Methods: Patients diagnosed with potentially curable esophageal or gastric cancer between 2015 and 2018 as registered in the Netherlands Cancer Registry were included. Data on overall survival was available for all patients, data on cancer-specific and recurrence-free survival and HRQoL was available for subgroups. Patients were classified according to diagnosis in hospitals with low, medium or high probability of treatment with curative intent (LP, MP or HP). Multivariable models were used to assess the association between LP, MP and HP hospitals and HRQoL and survival. Results: This study includes 7,199 patients with esophageal, and 2,407 with gastric cancer. Overall and cancer-specific survival was better for patients diagnosed in HP versus LP hospitals for both esophageal (HR = 0.82, 95%CI:0.77–0.88 and HR = 0.82, 95%CI:0.75–0.91, respectively), and gastric cancer (HR = 0.82, 95%CI:0.73–0.92 and HR = 0.74, 95%CI:0.64–0.87, respectively). These differences disappeared after adjustments for treatment. Recurrence-free survival was worse for gastric cancer patients diagnosed in HP hospitals (HR = 1.50, 95%CI:1.14–1.96), which disappeared after adjustment for radicality of surgery. Minor, but no clinically relevant, differences in HRQoL were observed. Conclusions: Patients diagnosed in hospitals with a high probability of treatment with curative intent have a better overall and cancer-specific but not recurrence-free survival, while minor differences in HRQoL were observed
Long-Term Outcome of Patients With a Hematologic Malignancy and Multiple Organ Failure Admitted at the Intensive Care
Objectives: Historically, patients with a hematologic malignancy
have one of the highest mortality rates among cancer patients
admitted to the ICU. Therefore, physicians are often reluctant to
admit these patients to the ICU. The aim of our study was to examine the survival of patients who have a hematologic malignancy
and multiple organ failure admitted to the ICU.
Design: This retrospective cohort study, part of the HEMA-ICU
study group, was designed to study the survival of patients with a
hematologic malignancy and organ failure after admission to the
ICU. Patients were followed for at least 1 year.
Setting: Five university hospitals in the Netherlands.
Patients: One-thousand ninety-seven patients with a hematologic
malignancy who were admitted at the ICU.
Interventions: None.
Measurements and Main Results: Primary outcome was 1-year
survival. Organ failure was categorized as acute kidney injury,
respiratory failure, hepatic failure, and hemodynamic failure; multiple organ failure was defined as failure of two or more organs.
The World Health Organization performance score measured 3
months after discharge from the ICU was used as a measure of
functional outcome. The 1-year survival rate among these patients
was 38%. Multiple organ failure was inversely associated with
long-term survival, and an absence of respiratory failure was the
strongest predictor of 1-year survival. The survival rate among
patients with 2, 3, and 4 failing organs was 27%, 22%, and 8%,
respectively. Among all surviving patients for which World Health Organization scores were available, 39% had a World Health
Organization performance score of 0–1 3 months after ICU discharge. Functional outcome was not associated with the number
of failing organs.
Conclusions: Our results suggest that multiple organ failure
should not be used as a criterion for excluding a patient with a
hematologic malignancy from admission to the ICU
Effect of a prediction tool and communication skills training on communication of treatment outcomes: a multicenter stepped wedge clinical trial (the SOURCE trial)
Background: For cancer patients to effectively engage in decision making, they require comprehensive and understandable information regarding treatment options and their associated outcomes. We developed an online prediction tool and supporting communication skills training to assist healthcare providers (HCPs) in this complex task. This study aims to assess the impact of this combined intervention (prediction tool and training) on the communication practices of HCPs when discussing treatment options. Methods: We conducted a multicenter intervention trial using a pragmatic stepped wedge design (NCT04232735). Standardized Patient Assessments (simulated consultations) using cases of esophageal and gastric cancer patients, were performed before and after the combined intervention (March 2020 to July 2022). Audio recordings were analyzed using an observational coding scale, rating all utterances of treatment outcome information on the primary outcome–precision of provided outcome information–and on secondary outcomes–such as: personalization, tailoring and use of visualizations. Pre vs. post measurements were compared in order to assess the effect of the intervention. Findings: 31 HCPs of 11 different centers in the Netherlands participated. The tool and training significantly affected the precision of the overall communicated treatment outcome information (p = 0.001, median difference 6.93, IQR (−0.32 to 12.44)). In the curative setting, survival information was significantly more precise after the intervention (p = 0.029). In the palliative setting, information about side effects was more precise (p < 0.001). Interpretation: A prediction tool and communication skills training for HCPs improves the precision of treatment information on outcomes in simulated consultations. The next step is to examine the effect of such interventions on communication in clinical practice and on patient-reported outcomes. Funding: Financial support for this study was provided entirely by a grant from the Dutch Cancer Society (UVA 2014-7000)
Myoclonus in comatose patients with electrographic status epilepticus after cardiac arrest: corresponding EEG patterns, effects of treatment and outcomes
Objective: To clarify the significance of any form of myoclonus in comatose patients after cardiac arrest with rhythmic and periodic EEG patterns (RPPs) by analyzing associations between myoclonus and EEG pattern, response to anti-seizure medication and neurological outcome.Design: Post hoc analysis of the prospective randomized Treatment of ELectroencephalographic STatus Epilepticus After Cardiopulmonary Resus-citation (TELSTAR) trial.Setting: Eleven ICUs in the Netherlands and Belgium.Patients: One hundred and fifty-seven adult comatose post-cardiac arrest patients with RPPs on continuous EEG monitoring. Interventions: Anti-seizure medication vs no anti-seizure medication in addition to standard care.Measurements and Main Results: Of 157 patients, 98 (63%) had myoclonus at inclusion. Myoclonus was not associated with one specific RPP type. However, myoclonus was associated with a smaller probability of a continuous EEG background pattern (48% in patients with vs 75% without myoclonus, odds ratio (OR) 0.31; 95% confidence interval (CI) 0.16-0.64) and earlier onset of RPPs (24% vs 9% within 24 hours after cardiac arrest, OR 3.86;95% CI 1.64-9.11). Myoclonus was associated with poor outcome at three months, but not invariably so (poor neurological outcome in 96% vs 82%, p = 0.004). Anti-seizure medication did not improve outcome, regardless of myoclonus presence (6% good outcome in the intervention group vs 2% in the control group, OR 0.33; 95% CI 0.03-3.32).Conclusions: Myoclonus in comatose patients after cardiac arrest with RPPs is associated with poor outcome and discontinuous or suppressed EEG. However, presence of myoclonus does not interact with the effects of anti-seizure medication and cannot predict a poor outcome without false positives.Neurological Motor Disorder
Nanostructured partially stabilized zirconia as an interlayer in a multi layered thermal barrier coating
Stresses developed within a thermal barrier coating (TBC) due to the mismatch in thermal expansion of different coating components causes coating failure. Nanostructured materials have an increased volume fraction of grain boundaries and this microstructural attribute may allow coatings to relieve the strain in the coating structure; thereby improving the effectiveness and the lifetime of the TBC. Multi – layered TBCs were prepared using two techniques; atmospheric pressure plasma spray using a commercial system, and reduced pressure plasma spray using the Triple Torch Plasma Reactor. The coatings were deposited on mullite and on NiCrAlY-coated steel substrates, and consisted of an inter layer of nano-phase partially stabilized zirconia (n-PSZ) and a layer of yttria stabilized zirconia coating (YSZ) as the top thermal barrier coat. The coatings were heat treated at various temperatures and the microstructural changes analyzed using scanning electron microscopy (SEM) images. It was observed that the changes in porosity, a critical microstructural feature that is necessary for the coatings to perform under operational conditions were not altered significantly - the data lay within the estimated deviations of the image analysis measurements. Mechanical properties of the coating were studied using micro-indentation and four point bend testing to better understand the effect of the n-PSZ inter-layer on the strain relief mechanisms that may be operative within the TBC